News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Link Technologies Ltd Release: Guidance on Selecting the Right PCR Fluorophore and Quenchers



5/8/2013 10:32:35 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

BELLSHILL, SCOTLAND, 8th May 2013: Link Technologies Ltd, an ISO 9001:2008 certified specialist oligonucleotide reagent manufacturer, will be attending the 15th anniversary of TIDES, Oligonucleotide and Peptide® Therapeutics: From Research through Commercialisation, on May 12–15, at the Hynes Convention Centre, Boston. On Tuesday, May 14 at 4.15 pm, Link Technologies’ Technical Manager, Dr Catherine McKeen, will be advising delegates in the most suitable selection of fluorescent labels and quenchers for various PCR applications, as one of a panel of experts in an audience discussion on the topic. The discussion will highlight the commercial consequences determined by the choice of quencher molecules, their linker structure and attachment chemistry, as well as other aspects that are fundamental to minimising re-validation costs and downstream delays, which need to be considered at the start of the process. The audience will be encouraged to ask questions and participate during the session to maximise its effect in helping to overcome the toughest challenges.

Link Technologies will be sharing booth 330 with its American distributor, AIC, at TIDES, which has become established as the key meeting place for companies working within the oligo and peptide industry, from discovery to manufacturing. Link representatives will be handing out the new Link Technologies Product Guide, which includes extensive application notes and easy to locate protocols, in paper format and on USB flash drives.

For more information please visit the Link Technologies website at www.linktech.co.uk or follow us on Twitter: @linktechdna.

About Link Technologies Ltd

Link Technologies Ltd is a leading kilo-scale supplier of speciality reagents for oligonucleotide synthesis and modification, all to the ISO 9001:2008 quality certification. The company’s main markets are university and commercial research departments, plus, increasingly, larger Contract Manufacturing Organisations (CMOs) in the biotech sector.

Link has also forged successful links to academia working closely with many UK universities. In tandem with internal research and development, the Company has an excellent record in bringing in-licence products to market with various worldwide commercial partners.

For further information see: www.linktech.co.uk.



Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES